Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study (scientific article)

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

Q32041499

Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities

Q33309750

Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial

Q33313869

Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa

Q33336603

Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics

Q33668265

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

Q34168214

A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?

Q34426356

Living with discordance: knowledge, challenges, and prevention strategies of HIV-discordant couples in Uganda

Q34452778

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

Q34470594

Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women

Q34639209

Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women

Q34853627

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics

Q35691394

Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa

Q35821445

Synergistic interactions between herpes simplex virus type-2 and human immunodeficiency virus epidemics

Q36165390

Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation

Q36267182

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

Q36331074

Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection

Q36729580

The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.

Q36827125

Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa

Q36849824

HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy

Q36879257

Effect of herpes simplex suppression on incidence of HIV among women in Tanzania

Q37098217

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

Q37114698

Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial

Q37149672

Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults

Q37153916

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

Q37357668

Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.

Q37860127

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

Q38885289

Factors affecting HIV concordancy in married couples in four African cities.

Q39011427

Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract

Q39787490

The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia

Q39839730

Molecular basis of the interactions between herpes simplex viruses and HIV-1.

Q43897703

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus

Q43932851

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

Q44226643

Active replication of human immunodeficiency virus type 1 by peripheral blood mononuclear cells following coincubation with herpes viruses

Q44984520

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial

Q45399240

Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations

Q45628713

Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial

Q45654235

Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women

Q45723058

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

Q45754911

Herpes simplex virus type 2 in the United States, 1976 to 1994.

Q45760165

The impact of active herpes simplex virus infection on human immunodeficiency virus load

Q45760630

Activation of human immunodeficiency virus by herpes simplex virus

Q45874718

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand

Q46454455

African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories

Q46519825

Enrollment and retention of HIV discordant couples in Lusaka, Zambia

Q46536705

Sexual behavior of HIV discordant couples after HIV counseling and testing

Q73149539

Interpersonal issues surrounding HIV counseling and testing, and the phenomenon of "testing by proxy"

Q82825989

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P921

main subject

Human herpesvirus 2

Q18965147

HIV transmission

Q49029021

P304

page(s)

e5272

P577

publication date

2009-04-30

P1433

published in

PLOS One

Q564954

P1476

title

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study

P478

volume

Reverse relations

cites work (P2860)

Q35834251	A new approach to measuring partnership concurrency and its association with HIV risk in couples
Q37032078	A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples
Q37503505	A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women
Q37598617	A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya
Q33727305	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Q36750843	An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention
Q24201657	Behavioral interventions for improving contraceptive use among women living with HIV
Q26470476	Behavioral interventions for improving contraceptive use among women living with HIV
Q24197792	Behavioral interventions for improving dual-method contraceptive use
Q36946237	Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy
Q33999996	Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial
Q35180117	Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence
Q37598620	Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships
Q34071194	Contribution of sexually transmitted infections to the sexual transmission of HIV.
Q37042078	Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence
Q33552342	Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?
Q33881449	Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
Q37212998	Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial
Q34030252	Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples
Q36991315	Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia
Q35007321	Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa
Q34920252	Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission
Q29417004	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure
Q37798349	HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis
Q36545046	HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples
Q28541918	HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077
Q33874874	HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples
Q33734155	High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa
Q37088950	Hormonal contraceptive use and risk of HIV-1 disease progression
Q35214337	Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples
Q34799419	Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition
Q34058693	Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples
Q34468239	Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial
Q33577360	My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda
Q34081339	Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study
Q35613315	Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships
Q36509600	Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters
Q34734012	Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries
Q35661895	Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples
Q35794339	Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment
Q34634872	Predicting pregnancy in HIV-1-discordant couples
Q44388082	Predictors of HIV Serodiscordance among Couples in Southwestern Ethiopia
Q36220941	Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa
Q35832093	Qualitative analysis of an educational intervention with HIV-discordant heterosexual Latino couples.
Q34555604	Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults
Q58765180	Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya
Q36757634	Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial
Q28487926	The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies
Q30558707	The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda
Q35036141	The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe
Q40484716	Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment
Q40575585	Undisclosed HIV infection and art use in the kenya AIDS indicator survey 2012: relevance to targets for HIV diagnosis and treatment in kenya
Q37503472	Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study
Q35699938	Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study
Q37614961	Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission
Q33844706	Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial
Q88586767	Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa
Q45812682	Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.

P819	ADS bibcode	2009PLoSO...4.5272L
P356	DOI	10.1371/JOURNAL.PONE.0005272
P932	PMC publication ID	2671170
P698	PubMed publication ID	19404392
P5875	ResearchGate publication ID	24379173